CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Optimal Cycles of Docetaxel-Based Systemic Chemotherapy in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC)
Sung Hoon Ahn , Seung Chol Park
Korean J Urol Oncol. 2013;11(2):105-108.   Published online 2013 August 30

Excel Download

Intermittent Chemotherapy with Docetaxel for Metastatic Castration-Resistant Prostate Cancer
Hormone Therapy and Castration Resistance of Prostate Cancer. 2018;357-368   Crossref logo
Link1

Docetaxel-based systemic chemotherapy in elderly Korean men with castration-resistant prostate cancer
Actas Urol├│gicas Espa├▒olas (English Edition). 2012;36(7):425-430   Crossref logo
Link1 Link2

Prostate-specific antigen testing in men with metastatic castration-resistant prostate cancer treated with docetaxel chemotherapy
Urological Science. 2015;26(4):277   Crossref logo
Link1 Link2

Systemic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
Management of Advanced Prostate Cancer. 2018;167-173   Crossref logo
Link1

S52 EFFICACY OF DOCETAXEL-BASED CHEMOTHERAPY IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
European Urology Supplements. 2012;11(4):145   Crossref logo
Link1 Link2

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer
BJU International. 2012;110(11b):E575-E582   Crossref logo
Link1 Link2

Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy
Medical Oncology. 2013;30(4):   Crossref logo
Link1 Link2 Link3

Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
Prostate Cancer and Prostatic Diseases. 2010;13(2):108-116   Crossref logo
Link1 Link2 Link3

581 RE-TREATMENT WITH DOCETAXEL IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC)
Journal of Urology. 2010;183(4S):   Crossref logo
Link1 Link2

896 RE-TREATMENT WITH DOCETAXEL IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC)
European Urology Supplements. 2010;9(2):283   Crossref logo
Link1 Link2